FABP3, the most abundant protein we found in metastatic tumors, has been implicated in renal cell carcinoma, esophageal adenocarcinoma [49, 50] and as a mammary-derived growth inhibitor [51]. The gene discussed is FABP3; the disease is metastatic neoplasm.